Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DE58RZ
|
|||
| Drug Name |
CUE-101
|
|||
| Drug Type |
Recombinant?protein
|
|||
| Indication | Oropharyngeal squamous cell carcinoma [ICD-11: 2B6A.0; ICD-9: 199] | Phase 2 | [1] | |
| Company |
Cue Biopharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04852328) Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.